Anavex Life Sciences Corp. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AVXL Nasdaq 2836 www.anavex.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Anavex Life Sciences Corp.

Penny Stocks To Watch In May 2026 - May 29th, 2026 6:05 am
Exploring High Growth Tech Stocks In The US Market May 2026 - May 28th, 2026 5:38 am
Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification - May 22nd, 2026 6:00 am
CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus - May 6th, 2026 8:52 am
Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer - May 6th, 2026 5:00 am
AMD downgraded, Airbnb upgraded: Wall Street's top analyst calls - May 4th, 2026 7:43 am
Exploring Three High Growth Tech Stocks In The US Market - Apr 29th, 2026 5:38 am
What Makes Anavex Life Sciences (AVXL) One of the Best Shorted Penny Stocks - Apr 26th, 2026 9:13 am
Anavex Life Sciences Teases New Pivotal Blarcamesine Trials, Maps Regulatory Path at Needham Conference - Apr 14th, 2026 10:05 pm
Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease - Apr 14th, 2026 5:30 am
Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference - Apr 7th, 2026 5:30 am
3 Promising Penny Stocks With At Least $200M Market Cap - Apr 2nd, 2026 12:05 pm
High Growth Tech Stocks in US for March 2026 - Mar 31st, 2026 11:38 am
Anavex Life Sciences Provides Comprehensive Regulatory Update - Mar 30th, 2026 5:30 am
Anavex Life Sciences Stock Is Deeply Oversold. Should You Buy the Dip? - Mar 26th, 2026 8:10 am
Here's Why We're Not Too Worried About Anavex Life Sciences' (NASDAQ:AVXL) Cash Burn Situation - Mar 26th, 2026 5:36 am
Top Midday Decliners - Mar 25th, 2026 11:35 am
Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease - Mar 25th, 2026 5:30 am
Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease - Mar 23rd, 2026 5:30 am
New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease - Mar 20th, 2026 5:30 am